% of Cases treated with Chemotherapy
| Country average (population) | Country average (country) | England | Scotland | Northern Ireland | Wales | Republic of Ireland | |
|---|---|---|---|---|---|---|---|
| All invasive xnmsc | 26.6% | 26.7% | 26.6% | 25.5% | 28.0% | ||
| All xnmsc 0-24 | 59.2% | 60.1% | 59.4% | 54.5% | 66.3% | ||
| All xnmsc 25-59 | 40.0% | 41.2% | 39.8% | 41.3% | 42.5% | ||
| All xnmsc 60-79 | 27.3% | 26.7% | 27.6% | 25.3% | 27.3% | ||
| All xnmsc 80+ | 8.4% | 8.2% | 8.6% | 6.1% | 9.9% | ||
| Haematology | 53.0% | 55.8% | 52.6% | 55.0% | 59.9% | ||
| Head and Neck | 30.0% | 25.2% | 31.1% | 23.6% | 20.8% | ||
| Lower GI | 32.4% | 31.0% | 32.6% | 31.2% | 29.3% | ||
| Upper GI | 39.9% | 40.9% | 40.1% | 37.0% | 45.7% | ||
| HPB | 23.6% | 23.9% | 24.0% | 17.6% | 30.0% | ||
| Trachea, Bronchus & Lung | 27.1% | 24.3% | 27.9% | 21.5% | 23.5% | ||
| Melanoma of skin | 1.4% | 2.1% | 1.4% | 0.1% | 4.8% | ||
| Breast | 32.4% | 34.5% | 32.2% | 31.5% | 39.9% | ||
| Cervix | 37.5% | 41.1% | 36.7% | 41.6% | 45.1% | ||
| Other Female Genitals | 30.1% | 32.4% | 29.6% | 34.7% | 32.9% | ||
| Prostate | 6.2% | 6.7% | 6.0% | 8.5% | 5.6% | ||
| Kidney | 8.1% | 6.8% | 8.5% | 2.5% | 9.4% | ||
| Bladder | 29.3% | 26.4% | 29.7% | 27.9% | 21.7% | ||
| Brain and CNS | 30.2% | 31.3% | 30.0% | 31.4% | 32.6% | ||
| Thyroid & other endocrine glands | 4.5% | 3.2% | 4.7% | 3.1% | 1.9% | ||
| CUP | 11.8% | 10.5% | 12.1% | 9.1% | 10.2% | ||
| Other invasive cancer | 29.3% | 28.5% | 29.6% | 26.9% | 29.1% | ||
| Breast in situ | 1.8% | 1.6% | 1.9% | 0.9% | 2.0% | ||
| Cervix in situ | 0.0% | 0.0% | 0.0% | 0.0% | 0.1% | ||
| Other tumours | 12.6% | 11.3% | 13.0% | 12.6% | 8.3% | ||
| Non-Melanoma Skin Cancer | 0.2% | 0.5% | 0.1% | 0.7% | 0.8% |